| 0 |
DEVICE INFORMATION OUTPUT ISSUE |
7077 |
0.9080 |
| 1 |
DEVICE CHEMICAL PROPERTY ISSUE |
54 |
0.8060 |
| 2 |
AIR IN DEVICE ISSUE |
31 |
0.7209 |
| 3 |
PATIENT-DEVICE INTERACTION ISSUE |
34 |
0.6939 |
| 4 |
DEVICE CALIBRATION FAILURE |
32 |
0.6038 |
| 5 |
DEVICE MECHANICAL ISSUE |
8152 |
0.5940 |
| 6 |
DEVICE POWER SOURCE ISSUE |
1635 |
0.5595 |
| 7 |
CRANIOPHARYNGIOMA |
185 |
0.5572 |
| 8 |
EXPIRED DEVICE USED |
1463 |
0.4408 |
| 9 |
DEVICE USER INTERFACE ISSUE |
15 |
0.4167 |
| 10 |
INSULIN-LIKE GROWTH FACTOR DECREASED |
216 |
0.4083 |
| 11 |
DEVICE PHYSICAL PROPERTY ISSUE |
3050 |
0.3977 |
| 12 |
DRUG ADMINISTERED IN WRONG DEVICE |
368 |
0.3759 |
| 13 |
DEVICE MATERIAL ISSUE |
791 |
0.3758 |
| 14 |
EPIPHYSIOLYSIS |
90 |
0.3614 |
| 15 |
GLIONEURONAL TUMOUR |
19 |
0.3519 |
| 16 |
BLOOD GROWTH HORMONE DECREASED |
70 |
0.3465 |
| 17 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
791 |
0.3329 |
| 18 |
PITUITARY TUMOUR RECURRENT |
56 |
0.3218 |
| 19 |
POOR QUALITY DEVICE USED |
3210 |
0.3196 |
| 20 |
DEVICE MATERIAL OPACIFICATION |
14 |
0.3111 |
| 21 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
390 |
0.2733 |
| 22 |
SEPTO-OPTIC DYSPLASIA |
18 |
0.2727 |
| 23 |
WRONG DEVICE USED |
175 |
0.2668 |
| 24 |
DEVICE LEAKAGE |
11126 |
0.2563 |
| 25 |
DRUG DOSE OMISSION BY DEVICE |
19220 |
0.2452 |
| 26 |
DEVICE BREAKAGE |
9710 |
0.2390 |
| 27 |
GERM CELL CANCER |
31 |
0.2138 |
| 28 |
ADENOIDAL HYPERTROPHY |
77 |
0.2037 |
| 29 |
INADVERTENT INJECTION AIR BUBBLE |
24 |
0.1905 |
| 30 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
170 |
0.1899 |
| 31 |
BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED |
55 |
0.1897 |
| 32 |
MEDULLOBLASTOMA RECURRENT |
21 |
0.1858 |
| 33 |
OSTEOCHONDROMA |
22 |
0.1849 |
| 34 |
MEDULLOBLASTOMA |
25 |
0.1678 |
| 35 |
PRODUCT KNOWLEDGE DEFICIT |
129 |
0.1650 |
| 36 |
HEPATOBLASTOMA |
16 |
0.1649 |
| 37 |
DEVICE USE ISSUE |
2834 |
0.1618 |
| 38 |
EPIPHYSES PREMATURE FUSION |
49 |
0.1617 |
| 39 |
DEVICE ELECTRICAL FINDING |
114 |
0.1610 |
| 40 |
BONE DENSITY INCREASED |
59 |
0.1479 |
| 41 |
BLOOD GROWTH HORMONE ABNORMAL |
18 |
0.1475 |
| 42 |
CEREBRAL SALT-WASTING SYNDROME |
14 |
0.1414 |
| 43 |
GROWTH HORMONE DEFICIENCY |
56 |
0.1411 |
| 44 |
GROWING PAINS |
38 |
0.1402 |
| 45 |
GROWTH FAILURE |
47 |
0.1366 |
| 46 |
PITUITARY CYST |
15 |
0.1351 |
| 47 |
DEVICE DEFECTIVE |
2335 |
0.1346 |
| 48 |
NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED |
34 |
0.1259 |
| 49 |
DEVICE DISPENSING ERROR |
140 |
0.1185 |
| 50 |
ACROMEGALY |
37 |
0.1167 |
| 51 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2875 |
0.1096 |
| 52 |
LIQUID PRODUCT PHYSICAL ISSUE |
792 |
0.1085 |
| 53 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
5061 |
0.1082 |
| 54 |
GROWTH DISORDER |
28 |
0.1037 |
| 55 |
GROWTH ACCELERATED |
22 |
0.1019 |
| 56 |
DEVICE USE ERROR |
3445 |
0.0990 |
| 57 |
PITUITARY TUMOUR BENIGN |
159 |
0.0974 |
| 58 |
ALBUMIN GLOBULIN RATIO INCREASED |
13 |
0.0949 |
| 59 |
DEVICE DELIVERY SYSTEM ISSUE |
2532 |
0.0924 |
| 60 |
OSTEOCHONDROSIS |
105 |
0.0904 |
| 61 |
GROWTH RETARDATION |
251 |
0.0852 |
| 62 |
PITUITARY TUMOUR |
127 |
0.0851 |
| 63 |
ASTROCYTOMA |
32 |
0.0810 |
| 64 |
BLOOD FOLLICLE STIMULATING HORMONE DECREASED |
14 |
0.0795 |
| 65 |
PATIENT-DEVICE INCOMPATIBILITY |
54 |
0.0791 |
| 66 |
DEVICE USE CONFUSION |
41 |
0.0784 |
| 67 |
DEVICE FAILURE |
1178 |
0.0773 |
| 68 |
DEVICE CONNECTION ISSUE |
149 |
0.0705 |
| 69 |
ADENOIDAL DISORDER |
18 |
0.0692 |
| 70 |
CREUTZFELDT-JAKOB DISEASE |
20 |
0.0692 |
| 71 |
PRECOCIOUS PUBERTY |
39 |
0.0683 |
| 72 |
PRODUCT CONTAMINATION WITH BODY FLUID |
14 |
0.0683 |
| 73 |
THYROXINE FREE DECREASED |
38 |
0.0673 |
| 74 |
NEUROFIBROMATOSIS |
14 |
0.0670 |
| 75 |
BLOOD GROWTH HORMONE INCREASED |
37 |
0.0663 |
| 76 |
PRIMARY HYPOTHYROIDISM |
14 |
0.0660 |
| 77 |
INJECTION SITE DISCHARGE |
354 |
0.0658 |
| 78 |
DEVICE ISSUE |
5869 |
0.0654 |
| 79 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
25 |
0.0639 |
| 80 |
BONE DEVELOPMENT ABNORMAL |
18 |
0.0632 |
| 81 |
DELAYED PUBERTY |
16 |
0.0630 |
| 82 |
DEVICE OCCLUSION |
863 |
0.0613 |
| 83 |
SYRINGOMYELIA |
17 |
0.0612 |
| 84 |
HYPOTHALAMO-PITUITARY DISORDER |
89 |
0.0611 |
| 85 |
NEOPLASM RECURRENCE |
201 |
0.0592 |
| 86 |
HYPONATRAEMIC SEIZURE |
14 |
0.0551 |
| 87 |
MALOCCLUSION |
16 |
0.0548 |
| 88 |
DOSE CALCULATION ERROR |
32 |
0.0546 |
| 89 |
BLOOD INSULIN INCREASED |
30 |
0.0543 |
| 90 |
TONSILLAR DISORDER |
61 |
0.0542 |
| 91 |
ADENOIDECTOMY |
21 |
0.0541 |
| 92 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
105 |
0.0538 |
| 93 |
PRODUCT SUBSTITUTION |
21 |
0.0520 |
| 94 |
PRODUCT PRESCRIBING ERROR |
1221 |
0.0512 |
| 95 |
PRODUCT COMMUNICATION ISSUE |
444 |
0.0503 |
| 96 |
PRODUCT DEPOSIT |
78 |
0.0500 |
| 97 |
THYROXINE INCREASED |
35 |
0.0496 |
| 98 |
LACK OF ADMINISTRATION SITE ROTATION |
14 |
0.0459 |
| 99 |
REACTION TO PRESERVATIVES |
35 |
0.0430 |
| 100 |
SCOLIOSIS |
260 |
0.0419 |
| 101 |
DEVICE OPERATIONAL ISSUE |
180 |
0.0418 |
| 102 |
OSTEOSARCOMA |
16 |
0.0416 |
| 103 |
HYPOPITUITARISM |
69 |
0.0396 |
| 104 |
ARNOLD-CHIARI MALFORMATION |
37 |
0.0388 |
| 105 |
TONSILLAR HYPERTROPHY |
64 |
0.0380 |
| 106 |
CEREBRAL CYST |
26 |
0.0378 |
| 107 |
PROTEIN-LOSING GASTROENTEROPATHY |
18 |
0.0362 |
| 108 |
NEEDLE ISSUE |
1054 |
0.0362 |
| 109 |
DEVICE MALFUNCTION |
2429 |
0.0345 |
| 110 |
PRODUCT PREPARATION ISSUE |
226 |
0.0344 |
| 111 |
THYROXINE FREE INCREASED |
22 |
0.0344 |
| 112 |
BRAIN NEOPLASM |
315 |
0.0343 |
| 113 |
EXPOSURE VIA EYE CONTACT |
14 |
0.0333 |
| 114 |
THYROXINE DECREASED |
20 |
0.0323 |
| 115 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1076 |
0.0318 |
| 116 |
GLIOMA |
20 |
0.0311 |
| 117 |
EXPOSURE VIA SKIN CONTACT |
798 |
0.0308 |
| 118 |
BLOOD CORTICOTROPHIN DECREASED |
15 |
0.0307 |
| 119 |
DEVICE BATTERY ISSUE |
20 |
0.0304 |
| 120 |
LACK OF INJECTION SITE ROTATION |
53 |
0.0303 |
| 121 |
BENIGN INTRACRANIAL HYPERTENSION |
37 |
0.0295 |
| 122 |
DEVICE LOOSENING |
25 |
0.0289 |
| 123 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
42 |
0.0288 |
| 124 |
WRONG DOSE |
69 |
0.0285 |
| 125 |
INTENTIONAL DEVICE MISUSE |
124 |
0.0281 |
| 126 |
FEAR OF INJECTION |
200 |
0.0280 |
| 127 |
PRODUCT CONTAMINATION PHYSICAL |
71 |
0.0279 |
| 128 |
BLOOD CREATININE DECREASED |
86 |
0.0274 |
| 129 |
DIABETES INSIPIDUS |
66 |
0.0274 |
| 130 |
SNORING |
102 |
0.0270 |
| 131 |
FOCAL NODULAR HYPERPLASIA |
14 |
0.0269 |
| 132 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
60 |
0.0267 |
| 133 |
HEPATIC ADENOMA |
13 |
0.0251 |
| 134 |
INTRACRANIAL PRESSURE INCREASED |
139 |
0.0249 |
| 135 |
BLOOD ALBUMIN INCREASED |
22 |
0.0247 |
| 136 |
PAPILLOEDEMA |
111 |
0.0246 |
| 137 |
PHAEOCHROMOCYTOMA |
16 |
0.0243 |
| 138 |
BLOOD IMMUNOGLOBULIN A INCREASED |
13 |
0.0241 |
| 139 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
132 |
0.0235 |
| 140 |
POOR QUALITY PRODUCT ADMINISTERED |
247 |
0.0234 |
| 141 |
MEAN PLATELET VOLUME INCREASED |
14 |
0.0232 |
| 142 |
KNEE DEFORMITY |
34 |
0.0229 |
| 143 |
CORTISOL INCREASED |
14 |
0.0224 |
| 144 |
DEVICE DIFFICULT TO USE |
1473 |
0.0222 |
| 145 |
LIMB ASYMMETRY |
17 |
0.0221 |
| 146 |
BLOOD CORTISOL DECREASED |
14 |
0.0219 |
| 147 |
DEVELOPMENTAL HIP DYSPLASIA |
18 |
0.0216 |
| 148 |
PRODUCT SOLUBILITY ABNORMAL |
109 |
0.0216 |
| 149 |
ENDOCRINE DISORDER |
27 |
0.0210 |
| 150 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
33 |
0.0206 |
| 151 |
SUSPECTED OFF LABEL USE |
93 |
0.0206 |
| 152 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
93 |
0.0205 |
| 153 |
CORTISOL DECREASED |
23 |
0.0201 |
| 154 |
HYPERTROPHIC CARDIOMYOPATHY |
31 |
0.0200 |
| 155 |
CARBON DIOXIDE DECREASED |
22 |
0.0191 |
| 156 |
INJECTION SITE DISCOMFORT |
198 |
0.0188 |
| 157 |
HYPOGLYCAEMIC SEIZURE |
17 |
0.0187 |
| 158 |
INTENTIONAL DEVICE USE ISSUE |
16 |
0.0187 |
| 159 |
ANION GAP INCREASED |
25 |
0.0187 |
| 160 |
INJECTION SITE EXTRAVASATION |
224 |
0.0181 |
| 161 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
17 |
0.0179 |
| 162 |
INCORRECT DOSAGE ADMINISTERED |
87 |
0.0178 |
| 163 |
BLOOD TESTOSTERONE INCREASED |
38 |
0.0177 |
| 164 |
BLOOD UREA DECREASED |
21 |
0.0169 |
| 165 |
LIMB DEFORMITY |
26 |
0.0164 |
| 166 |
DRUG DELIVERY SYSTEM ISSUE |
32 |
0.0162 |
| 167 |
DEVICE DEPOSIT ISSUE |
33 |
0.0162 |
| 168 |
ADRENAL DISORDER |
31 |
0.0161 |
| 169 |
HORMONE LEVEL ABNORMAL |
78 |
0.0160 |
| 170 |
MEAN CELL HAEMOGLOBIN DECREASED |
29 |
0.0158 |
| 171 |
PRODUCT CONTAMINATION |
56 |
0.0157 |
| 172 |
GLIOBLASTOMA MULTIFORME |
13 |
0.0154 |
| 173 |
HIGH DENSITY LIPOPROTEIN DECREASED |
51 |
0.0153 |
| 174 |
DEVICE DEPLOYMENT ISSUE |
195 |
0.0152 |
| 175 |
CRYPTORCHISM |
17 |
0.0151 |
| 176 |
HAEMATOCRIT INCREASED |
34 |
0.0149 |
| 177 |
INSULIN RESISTANCE |
31 |
0.0149 |
| 178 |
FEBRILE CONVULSION |
18 |
0.0148 |
| 179 |
HEPATIC NECROSIS |
55 |
0.0146 |
| 180 |
SLEEP APNOEA SYNDROME |
275 |
0.0144 |
| 181 |
PRODUCT EXPIRATION DATE ISSUE |
20 |
0.0143 |
| 182 |
INJECTION SITE HAEMORRHAGE |
1138 |
0.0142 |
| 183 |
BLOOD SODIUM INCREASED |
38 |
0.0141 |
| 184 |
INJECTION SITE BRUISING |
1119 |
0.0140 |
| 185 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
23 |
0.0138 |
| 186 |
PRODUCT LEAKAGE |
77 |
0.0137 |
| 187 |
DENGUE FEVER |
31 |
0.0135 |
| 188 |
BLOOD CHLORIDE INCREASED |
23 |
0.0133 |
| 189 |
AUTISM SPECTRUM DISORDER |
73 |
0.0132 |
| 190 |
DEVICE SAFETY FEATURE ISSUE |
13 |
0.0132 |
| 191 |
PRODUCT ODOUR ABNORMAL |
138 |
0.0132 |
| 192 |
MEAN CELL VOLUME DECREASED |
20 |
0.0130 |
| 193 |
INCORRECT DOSE ADMINISTERED |
2831 |
0.0124 |
| 194 |
INJECTION SITE PAIN |
3770 |
0.0123 |
| 195 |
STRABISMUS |
36 |
0.0122 |
| 196 |
ADMINISTRATION SITE PAIN |
14 |
0.0121 |
| 197 |
SPINAL DEFORMITY |
20 |
0.0119 |
| 198 |
UNDERWEIGHT |
23 |
0.0117 |
| 199 |
PRODUCT DOSE OMISSION |
759 |
0.0116 |
| 200 |
INTERCEPTED PRODUCT SELECTION ERROR |
15 |
0.0115 |
| 201 |
OTITIS MEDIA |
38 |
0.0115 |
| 202 |
INJURY ASSOCIATED WITH DEVICE |
232 |
0.0114 |
| 203 |
TONSILLECTOMY |
19 |
0.0114 |
| 204 |
GLUCOSE TOLERANCE IMPAIRED |
67 |
0.0113 |
| 205 |
LIPODYSTROPHY ACQUIRED |
24 |
0.0113 |
| 206 |
TYPE 1 DIABETES MELLITUS |
68 |
0.0113 |
| 207 |
PRODUCT AVAILABILITY ISSUE |
257 |
0.0113 |
| 208 |
OFF LABEL USE OF DEVICE |
15 |
0.0111 |
| 209 |
INJECTION SITE ATROPHY |
18 |
0.0109 |
| 210 |
SKIN STRIAE |
16 |
0.0107 |
| 211 |
ENURESIS |
43 |
0.0106 |
| 212 |
APPENDIX DISORDER |
15 |
0.0106 |
| 213 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
14 |
0.0106 |
| 214 |
INJECTION SITE PARAESTHESIA |
16 |
0.0104 |
| 215 |
VITAMIN D DECREASED |
89 |
0.0104 |
| 216 |
HYPERPHAGIA |
41 |
0.0103 |
| 217 |
HYPERTRICHOSIS |
19 |
0.0102 |
| 218 |
POLYCYTHAEMIA |
21 |
0.0102 |
| 219 |
TONSILLITIS |
53 |
0.0101 |
| 220 |
RED BLOOD CELL COUNT INCREASED |
28 |
0.0101 |
| 221 |
HYDROCEPHALUS |
55 |
0.0101 |
| 222 |
PRODUCT STORAGE ERROR |
875 |
0.0100 |
| 223 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1006 |
0.0098 |
| 224 |
RENAL TRANSPLANT |
35 |
0.0097 |
| 225 |
SCREAMING |
61 |
0.0096 |
| 226 |
GLIOBLASTOMA |
16 |
0.0094 |
| 227 |
AORTIC VALVE DISEASE |
15 |
0.0093 |
| 228 |
PRODUCT PREPARATION ERROR |
190 |
0.0092 |
| 229 |
PAPILLARY THYROID CANCER |
16 |
0.0092 |
| 230 |
INJECTION SITE INJURY |
51 |
0.0092 |
| 231 |
INCORRECT DRUG ADMINISTRATION RATE |
38 |
0.0089 |
| 232 |
CRANIOCEREBRAL INJURY |
27 |
0.0089 |
| 233 |
RED CELL DISTRIBUTION WIDTH INCREASED |
37 |
0.0089 |
| 234 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
163 |
0.0089 |
| 235 |
PRODUCT DISPENSING ISSUE |
37 |
0.0086 |
| 236 |
SKIN ODOUR ABNORMAL |
34 |
0.0086 |
| 237 |
NEOPLASM |
99 |
0.0086 |
| 238 |
BLOOD PARATHYROID HORMONE INCREASED |
25 |
0.0086 |
| 239 |
LYMPHOCYTE COUNT INCREASED |
28 |
0.0086 |
| 240 |
PRODUCT LABEL CONFUSION |
50 |
0.0086 |
| 241 |
EDUCATIONAL PROBLEM |
14 |
0.0084 |
| 242 |
TYMPANIC MEMBRANE PERFORATION |
14 |
0.0083 |
| 243 |
INJECTION SITE VESICLES |
50 |
0.0083 |
| 244 |
PRODUCT SUPPLY ISSUE |
58 |
0.0081 |
| 245 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
50 |
0.0081 |
| 246 |
DEVICE INFUSION ISSUE |
20 |
0.0081 |
| 247 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
74 |
0.0080 |
| 248 |
UNDERDOSE |
587 |
0.0080 |
| 249 |
PRODUCT DISPENSING ERROR |
172 |
0.0079 |
| 250 |
BLOOD TESTOSTERONE DECREASED |
54 |
0.0079 |
| 251 |
JUVENILE IDIOPATHIC ARTHRITIS |
19 |
0.0078 |
| 252 |
INFECTIOUS MONONUCLEOSIS |
17 |
0.0076 |
| 253 |
VENTRICULAR HYPERTROPHY |
19 |
0.0076 |
| 254 |
BRAIN OPERATION |
17 |
0.0074 |
| 255 |
WRONG PATIENT RECEIVED MEDICATION |
20 |
0.0073 |
| 256 |
MELANOCYTIC NAEVUS |
32 |
0.0073 |
| 257 |
PRODUCT PHYSICAL ISSUE |
147 |
0.0073 |
| 258 |
TIBIA FRACTURE |
34 |
0.0072 |
| 259 |
APNOEA |
56 |
0.0072 |
| 260 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
123 |
0.0072 |
| 261 |
HAEMOGLOBIN INCREASED |
32 |
0.0070 |
| 262 |
MEAN CELL VOLUME INCREASED |
18 |
0.0070 |
| 263 |
VIITH NERVE PARALYSIS |
24 |
0.0069 |
| 264 |
LIPOMA |
18 |
0.0069 |
| 265 |
PRODUCT STORAGE ISSUE |
26 |
0.0069 |
| 266 |
BLOOD PROLACTIN INCREASED |
32 |
0.0068 |
| 267 |
HAIR GROWTH ABNORMAL |
46 |
0.0066 |
| 268 |
MONOCYTE COUNT INCREASED |
24 |
0.0066 |
| 269 |
ENERGY INCREASED |
39 |
0.0066 |
| 270 |
ASTHMATIC CRISIS |
24 |
0.0066 |
| 271 |
PRODUCT DOSE OMISSION ISSUE |
1927 |
0.0065 |
| 272 |
HYPOPHYSITIS |
13 |
0.0065 |
| 273 |
ELECTRIC SHOCK SENSATION |
18 |
0.0064 |
| 274 |
RECURRENT CANCER |
26 |
0.0064 |
| 275 |
PRODUCT USE COMPLAINT |
100 |
0.0063 |
| 276 |
INCREASED APPETITE |
121 |
0.0063 |
| 277 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
35 |
0.0063 |
| 278 |
INJECTION SITE SCAR |
18 |
0.0063 |
| 279 |
APPENDICITIS |
59 |
0.0063 |
| 280 |
PRODUCT CONTAINER ISSUE |
54 |
0.0063 |
| 281 |
BLOOD PHOSPHORUS INCREASED |
17 |
0.0062 |
| 282 |
BLOOD CHLORIDE DECREASED |
16 |
0.0062 |
| 283 |
LOW DENSITY LIPOPROTEIN INCREASED |
48 |
0.0062 |
| 284 |
THYROID NEOPLASM |
17 |
0.0062 |
| 285 |
CARPAL TUNNEL SYNDROME |
86 |
0.0061 |
| 286 |
PRE-EXISTING CONDITION IMPROVED |
38 |
0.0061 |
| 287 |
INJECTION SITE MASS |
224 |
0.0061 |
| 288 |
POOR QUALITY DRUG ADMINISTERED |
39 |
0.0060 |
| 289 |
INJECTION SITE DISCOLOURATION |
75 |
0.0060 |
| 290 |
CRYING |
218 |
0.0060 |
| 291 |
BREAST SWELLING |
16 |
0.0059 |
| 292 |
BLOOD TRIGLYCERIDES INCREASED |
105 |
0.0059 |
| 293 |
PRODUCT ADMINISTRATION ERROR |
120 |
0.0059 |
| 294 |
HEPATIC ENCEPHALOPATHY |
55 |
0.0059 |
| 295 |
GASTROENTERITIS |
86 |
0.0059 |
| 296 |
MYOPIA |
14 |
0.0059 |
| 297 |
VARICELLA |
14 |
0.0059 |
| 298 |
PRODUCT COLOUR ISSUE |
30 |
0.0058 |
| 299 |
NEPHROTIC SYNDROME |
40 |
0.0058 |
| 300 |
MENOPAUSE |
15 |
0.0058 |
| 301 |
BRAIN NEOPLASM MALIGNANT |
26 |
0.0058 |
| 302 |
FAILURE TO THRIVE |
30 |
0.0058 |
| 303 |
HYPERNATRAEMIA |
28 |
0.0056 |
| 304 |
EPILEPSY |
169 |
0.0055 |
| 305 |
ADRENAL INSUFFICIENCY |
67 |
0.0055 |
| 306 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
137 |
0.0055 |
| 307 |
THERAPY CHANGE |
54 |
0.0055 |
| 308 |
BRAIN INJURY |
55 |
0.0055 |
| 309 |
DRUG DOSE OMISSION |
902 |
0.0055 |
| 310 |
BEHAVIOUR DISORDER |
29 |
0.0054 |
| 311 |
PRODUCT ADMINISTRATION INTERRUPTED |
42 |
0.0053 |
| 312 |
VIRAL INFECTION |
177 |
0.0053 |
| 313 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
15 |
0.0053 |
| 314 |
INTENTIONAL DOSE OMISSION |
150 |
0.0053 |
| 315 |
SYRINGE ISSUE |
92 |
0.0053 |
| 316 |
EAR DISORDER |
24 |
0.0052 |
| 317 |
ACCIDENTAL OVERDOSE |
191 |
0.0052 |
| 318 |
PRODUCT LABEL ISSUE |
35 |
0.0052 |
| 319 |
CONCUSSION |
39 |
0.0050 |
| 320 |
VITAMIN D DEFICIENCY |
49 |
0.0050 |
| 321 |
MOOD ALTERED |
137 |
0.0050 |
| 322 |
THYROID DISORDER |
77 |
0.0050 |
| 323 |
MENINGIOMA |
78 |
0.0050 |
| 324 |
HUMERUS FRACTURE |
24 |
0.0050 |
| 325 |
ACCIDENT |
59 |
0.0049 |
| 326 |
OESOPHAGEAL DISORDER |
19 |
0.0049 |
| 327 |
BREAST ENLARGEMENT |
16 |
0.0049 |
| 328 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
25 |
0.0049 |
| 329 |
GASTROENTERITIS VIRAL |
87 |
0.0048 |
| 330 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
968 |
0.0048 |
| 331 |
TIC |
26 |
0.0048 |
| 332 |
UPPER LIMB FRACTURE |
93 |
0.0047 |
| 333 |
WOUND COMPLICATION |
16 |
0.0047 |
| 334 |
GOITRE |
19 |
0.0046 |
| 335 |
OBESITY |
73 |
0.0046 |
| 336 |
POLYDIPSIA |
18 |
0.0045 |
| 337 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
114 |
0.0045 |
| 338 |
HAND FRACTURE |
32 |
0.0045 |
| 339 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
19 |
0.0045 |
| 340 |
AUTOIMMUNE THYROIDITIS |
17 |
0.0045 |
| 341 |
BLOOD TEST ABNORMAL |
63 |
0.0045 |
| 342 |
BLOOD CALCIUM INCREASED |
39 |
0.0044 |
| 343 |
EAR INFECTION |
118 |
0.0044 |
| 344 |
HIP SURGERY |
24 |
0.0044 |
| 345 |
ABNORMAL BEHAVIOUR |
173 |
0.0044 |
| 346 |
INJECTION SITE HAEMATOMA |
63 |
0.0043 |
| 347 |
HYPOGLYCAEMIA |
209 |
0.0043 |
| 348 |
PETIT MAL EPILEPSY |
22 |
0.0043 |
| 349 |
HEPATIC NEOPLASM |
14 |
0.0043 |
| 350 |
DRUG DISPENSING ERROR |
65 |
0.0042 |
| 351 |
GASTROINTESTINAL INFECTION |
38 |
0.0042 |
| 352 |
PRESCRIBED OVERDOSE |
82 |
0.0042 |
| 353 |
CEREBRAL DISORDER |
31 |
0.0042 |
| 354 |
PHARMACEUTICAL PRODUCT COMPLAINT |
108 |
0.0042 |
| 355 |
METABOLIC DISORDER |
24 |
0.0041 |
| 356 |
SUSPECTED COUNTERFEIT PRODUCT |
16 |
0.0040 |
| 357 |
MENINGITIS |
27 |
0.0040 |
| 358 |
LEUKAEMIA |
38 |
0.0040 |
| 359 |
LOWER LIMB FRACTURE |
77 |
0.0040 |
| 360 |
IMPULSIVE BEHAVIOUR |
15 |
0.0040 |
| 361 |
EOSINOPHIL COUNT INCREASED |
33 |
0.0040 |
| 362 |
WEIGHT FLUCTUATION |
41 |
0.0039 |
| 363 |
THERAPY INTERRUPTED |
280 |
0.0039 |
| 364 |
OVERWEIGHT |
21 |
0.0039 |
| 365 |
HEPATIC CIRRHOSIS |
73 |
0.0039 |
| 366 |
PRODUCT DISTRIBUTION ISSUE |
36 |
0.0039 |
| 367 |
THERAPY CESSATION |
198 |
0.0039 |
| 368 |
DRUG PRESCRIBING ERROR |
74 |
0.0038 |
| 369 |
SEIZURE |
444 |
0.0038 |
| 370 |
AFFECTIVE DISORDER |
30 |
0.0038 |
| 371 |
PHARYNGITIS STREPTOCOCCAL |
41 |
0.0038 |
| 372 |
KIDNEY TRANSPLANT REJECTION |
18 |
0.0037 |
| 373 |
LEFT VENTRICULAR HYPERTROPHY |
16 |
0.0037 |
| 374 |
BRONCHIOLITIS |
13 |
0.0037 |
| 375 |
VARICOSE VEIN |
19 |
0.0037 |
| 376 |
HYPOTHYROIDISM |
117 |
0.0037 |
| 377 |
AGGRESSION |
182 |
0.0036 |
| 378 |
LIGAMENT RUPTURE |
16 |
0.0036 |
| 379 |
THYROID FUNCTION TEST ABNORMAL |
15 |
0.0036 |
| 380 |
RHINOVIRUS INFECTION |
14 |
0.0036 |
| 381 |
INCORRECT PRODUCT STORAGE |
47 |
0.0036 |
| 382 |
HEADACHE |
2239 |
0.0036 |
| 383 |
SCRATCH |
37 |
0.0035 |
| 384 |
WRIST FRACTURE |
42 |
0.0035 |
| 385 |
JOINT DISLOCATION |
37 |
0.0035 |
| 386 |
BLOOD SODIUM DECREASED |
65 |
0.0034 |
| 387 |
TENSION |
21 |
0.0034 |
| 388 |
INJECTION SITE INFLAMMATION |
17 |
0.0034 |
| 389 |
BONE DISORDER |
62 |
0.0034 |
| 390 |
PRODUCT PRESCRIBING ISSUE |
74 |
0.0034 |
| 391 |
EATING DISORDER |
72 |
0.0034 |
| 392 |
SPINAL DISORDER |
32 |
0.0034 |
| 393 |
INTENTIONAL PRODUCT MISUSE |
294 |
0.0034 |
| 394 |
LIMB OPERATION |
16 |
0.0033 |
| 395 |
BRAIN OEDEMA |
42 |
0.0033 |
| 396 |
MEDICATION ERROR |
183 |
0.0033 |
| 397 |
INGUINAL HERNIA |
20 |
0.0033 |
| 398 |
PARTIAL SEIZURES |
17 |
0.0032 |
| 399 |
HYPERSOMNIA |
93 |
0.0032 |
| 400 |
UMBILICAL HERNIA |
15 |
0.0032 |
| 401 |
BLOOD GLUCOSE DECREASED |
153 |
0.0032 |
| 402 |
FOOT DEFORMITY |
35 |
0.0032 |
| 403 |
BLOOD GLUCOSE ABNORMAL |
58 |
0.0031 |
| 404 |
PSYCHOMOTOR HYPERACTIVITY |
52 |
0.0031 |
| 405 |
DRUG DELIVERY SYSTEM MALFUNCTION |
16 |
0.0031 |
| 406 |
PRODUCT DOSE OMISSION IN ERROR |
88 |
0.0031 |
| 407 |
MUSCLE DISORDER |
25 |
0.0031 |
| 408 |
MALIGNANT MELANOMA |
41 |
0.0031 |
| 409 |
COELIAC DISEASE |
30 |
0.0031 |
| 410 |
PRODUCT PACKAGING ISSUE |
29 |
0.0030 |
| 411 |
ANGIOPATHY |
17 |
0.0030 |
| 412 |
WEIGHT INCREASED |
673 |
0.0030 |
| 413 |
ANGER |
101 |
0.0030 |
| 414 |
CYST |
37 |
0.0030 |
| 415 |
BREAST MASS |
20 |
0.0030 |
| 416 |
PRODUCT DELIVERY MECHANISM ISSUE |
16 |
0.0030 |
| 417 |
HYPERTHYROIDISM |
43 |
0.0030 |
| 418 |
JAW DISORDER |
16 |
0.0029 |
| 419 |
THERAPEUTIC RESPONSE UNEXPECTED |
131 |
0.0029 |
| 420 |
EXPIRED PRODUCT ADMINISTERED |
97 |
0.0029 |
| 421 |
THIRST |
52 |
0.0029 |
| 422 |
ANKLE FRACTURE |
45 |
0.0029 |
| 423 |
BREAST PAIN |
31 |
0.0029 |
| 424 |
INJECTION SITE RASH |
88 |
0.0029 |
| 425 |
APPETITE DISORDER |
19 |
0.0029 |
| 426 |
MASS |
40 |
0.0029 |
| 427 |
CONTUSION |
275 |
0.0029 |
| 428 |
FLUID RETENTION |
145 |
0.0028 |
| 429 |
LIGAMENT SPRAIN |
28 |
0.0028 |
| 430 |
OSTEONECROSIS |
93 |
0.0028 |
| 431 |
DISEASE RECURRENCE |
132 |
0.0028 |
| 432 |
NEOPLASM PROGRESSION |
96 |
0.0028 |
| 433 |
SUDDEN DEATH |
29 |
0.0027 |
| 434 |
HEPATOTOXICITY |
61 |
0.0027 |
| 435 |
BODY HEIGHT DECREASED |
29 |
0.0027 |
| 436 |
STREPTOCOCCAL INFECTION |
15 |
0.0027 |
| 437 |
IMMUNE SYSTEM DISORDER |
35 |
0.0027 |
| 438 |
HEPATOMEGALY |
26 |
0.0026 |
| 439 |
DRUG EFFECT LESS THAN EXPECTED |
39 |
0.0026 |
| 440 |
INITIAL INSOMNIA |
27 |
0.0026 |
| 441 |
VISUAL FIELD DEFECT |
19 |
0.0026 |
| 442 |
EMOTIONAL DISORDER |
81 |
0.0026 |
| 443 |
IRRITABILITY |
157 |
0.0026 |
| 444 |
STRESS FRACTURE |
14 |
0.0026 |
| 445 |
PIGMENTATION DISORDER |
16 |
0.0026 |
| 446 |
PRODUCT FORMULATION ISSUE |
17 |
0.0026 |
| 447 |
MEDICAL DEVICE COMPLICATION |
19 |
0.0026 |
| 448 |
BLOOD UREA INCREASED |
43 |
0.0026 |
| 449 |
POLYURIA |
21 |
0.0026 |
| 450 |
CARDIAC OPERATION |
22 |
0.0026 |
| 451 |
DEAFNESS UNILATERAL |
14 |
0.0025 |
| 452 |
PROSTATIC DISORDER |
14 |
0.0025 |
| 453 |
CONVULSION |
145 |
0.0025 |
| 454 |
MUSCLE ATROPHY |
32 |
0.0025 |
| 455 |
BLOOD CHOLESTEROL INCREASED |
117 |
0.0025 |
| 456 |
ELECTROLYTE IMBALANCE |
29 |
0.0025 |
| 457 |
INJECTION SITE SWELLING |
190 |
0.0025 |
| 458 |
PERIORBITAL SWELLING |
14 |
0.0025 |
| 459 |
PERSONALITY CHANGE |
23 |
0.0025 |
| 460 |
FOOD ALLERGY |
19 |
0.0025 |
| 461 |
MALAISE |
1078 |
0.0025 |
| 462 |
SUBARACHNOID HAEMORRHAGE |
25 |
0.0025 |
| 463 |
MYOSITIS |
22 |
0.0024 |
| 464 |
FRACTURE |
46 |
0.0024 |
| 465 |
FOOT FRACTURE |
46 |
0.0024 |
| 466 |
PALLOR |
66 |
0.0024 |
| 467 |
INFLUENZA |
269 |
0.0024 |
| 468 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
21 |
0.0024 |
| 469 |
NERVOUSNESS |
126 |
0.0024 |
| 470 |
ATRIOVENTRICULAR BLOCK COMPLETE |
16 |
0.0024 |
| 471 |
ILLNESS |
246 |
0.0024 |
| 472 |
MIGRAINE |
227 |
0.0024 |
| 473 |
BLOOD DISORDER |
19 |
0.0024 |
| 474 |
HUNGER |
33 |
0.0024 |
| 475 |
WRONG PRODUCT ADMINISTERED |
16 |
0.0024 |
| 476 |
LIMB INJURY |
64 |
0.0024 |
| 477 |
OFF LABEL USE |
2049 |
0.0023 |
| 478 |
OBSTRUCTIVE AIRWAYS DISORDER |
26 |
0.0023 |
| 479 |
BLINDNESS |
95 |
0.0023 |
| 480 |
LYMPHOMA |
36 |
0.0023 |
| 481 |
INJECTION SITE URTICARIA |
57 |
0.0023 |
| 482 |
PAIN IN EXTREMITY |
683 |
0.0023 |
| 483 |
BLOOD CALCIUM DECREASED |
26 |
0.0023 |
| 484 |
LETHARGY |
133 |
0.0023 |
| 485 |
HEAD INJURY |
73 |
0.0023 |
| 486 |
ARTHRALGIA |
959 |
0.0023 |
| 487 |
MOOD SWINGS |
73 |
0.0023 |
| 488 |
BONE PAIN |
134 |
0.0023 |
| 489 |
GLOMERULAR FILTRATION RATE DECREASED |
28 |
0.0023 |
| 490 |
GROIN PAIN |
20 |
0.0023 |
| 491 |
NEUTROPHIL COUNT INCREASED |
23 |
0.0022 |
| 492 |
THYROID CANCER |
27 |
0.0022 |
| 493 |
PRODUCT QUALITY ISSUE |
303 |
0.0022 |
| 494 |
FRUSTRATION TOLERANCE DECREASED |
18 |
0.0022 |
| 495 |
VISUAL ACUITY REDUCED |
74 |
0.0022 |
| 496 |
ROAD TRAFFIC ACCIDENT |
93 |
0.0022 |
| 497 |
SKIN LACERATION |
24 |
0.0022 |
| 498 |
PYREXIA |
763 |
0.0022 |
| 499 |
OVARIAN CYST |
22 |
0.0022 |
| 500 |
BLOOD GLUCOSE INCREASED |
413 |
0.0022 |
| 501 |
HAEMATOCRIT DECREASED |
43 |
0.0022 |
| 502 |
BLOOD POTASSIUM DECREASED |
65 |
0.0022 |
| 503 |
MENTAL DISORDER |
94 |
0.0022 |
| 504 |
ARTHROPATHY |
120 |
0.0022 |
| 505 |
SLUGGISHNESS |
22 |
0.0022 |
| 506 |
PLATELET COUNT INCREASED |
28 |
0.0021 |
| 507 |
BLOOD ALBUMIN DECREASED |
17 |
0.0021 |
| 508 |
DRUG-INDUCED LIVER INJURY |
67 |
0.0021 |
| 509 |
LABORATORY TEST ABNORMAL |
63 |
0.0021 |
| 510 |
PRODUCT USE IN UNAPPROVED INDICATION |
528 |
0.0021 |
| 511 |
OBSESSIVE-COMPULSIVE DISORDER |
17 |
0.0021 |
| 512 |
INABILITY TO AFFORD MEDICATION |
21 |
0.0021 |
| 513 |
DIABETES MELLITUS |
161 |
0.0021 |
| 514 |
DEVELOPMENTAL DELAY |
19 |
0.0021 |
| 515 |
EYE DISORDER |
69 |
0.0021 |
| 516 |
INJECTION SITE NODULE |
23 |
0.0021 |
| 517 |
POST PROCEDURAL COMPLICATION |
40 |
0.0021 |
| 518 |
EXOSTOSIS |
19 |
0.0021 |
| 519 |
SYNCOPE |
207 |
0.0021 |
| 520 |
HOSPITALISATION |
311 |
0.0020 |
| 521 |
JOINT INJURY |
43 |
0.0020 |
| 522 |
INJECTION SITE INDURATION |
26 |
0.0020 |
| 523 |
HYPOTONIA |
20 |
0.0020 |
| 524 |
EYE SWELLING |
74 |
0.0020 |
| 525 |
SURGERY |
116 |
0.0020 |
| 526 |
RENAL DISORDER |
91 |
0.0020 |
| 527 |
BLOOD IRON DECREASED |
23 |
0.0019 |
| 528 |
TEMPERATURE INTOLERANCE |
20 |
0.0019 |
| 529 |
INJECTION SITE REACTION |
133 |
0.0019 |
| 530 |
KNEE OPERATION |
19 |
0.0019 |
| 531 |
SLEEP DISORDER |
136 |
0.0019 |
| 532 |
BONE DENSITY DECREASED |
60 |
0.0019 |
| 533 |
LOWER RESPIRATORY TRACT INFECTION |
87 |
0.0019 |
| 534 |
NEOPLASM MALIGNANT |
127 |
0.0019 |
| 535 |
PERIPHERAL SWELLING |
293 |
0.0019 |
| 536 |
RESPIRATORY TRACT INFECTION |
49 |
0.0019 |
| 537 |
COLON CANCER |
28 |
0.0019 |
| 538 |
NASOPHARYNGITIS |
346 |
0.0019 |
| 539 |
TENDON RUPTURE |
23 |
0.0019 |
| 540 |
POOR QUALITY SLEEP |
40 |
0.0019 |
| 541 |
MEMORY IMPAIRMENT |
255 |
0.0019 |
| 542 |
EXTRA DOSE ADMINISTERED |
75 |
0.0018 |
| 543 |
AORTIC ANEURYSM |
14 |
0.0018 |
| 544 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
14 |
0.0018 |
| 545 |
BLOOD GLUCOSE FLUCTUATION |
20 |
0.0018 |
| 546 |
PULMONARY HYPERTENSION |
38 |
0.0018 |
| 547 |
INTENTIONAL PRODUCT USE ISSUE |
159 |
0.0018 |
| 548 |
TYPE 2 DIABETES MELLITUS |
61 |
0.0018 |
| 549 |
HYPERGLYCAEMIA |
66 |
0.0018 |
| 550 |
TREATMENT NONCOMPLIANCE |
99 |
0.0018 |
| 551 |
SWELLING FACE |
117 |
0.0018 |
| 552 |
BURNING SENSATION |
126 |
0.0018 |
| 553 |
BASAL CELL CARCINOMA |
28 |
0.0018 |
| 554 |
DRUG ADMINISTRATION ERROR |
55 |
0.0018 |
| 555 |
INJECTION SITE ERYTHEMA |
222 |
0.0018 |
| 556 |
SPINAL OPERATION |
22 |
0.0018 |
| 557 |
BACK DISORDER |
29 |
0.0018 |
| 558 |
OSTEOPENIA |
27 |
0.0018 |
| 559 |
ARTHROPOD BITE |
13 |
0.0018 |
| 560 |
NECK PAIN |
98 |
0.0018 |
| 561 |
DIZZINESS POSTURAL |
17 |
0.0018 |
| 562 |
WEIGHT DECREASED |
489 |
0.0017 |
| 563 |
DEPRESSED MOOD |
92 |
0.0017 |
| 564 |
RHINITIS |
14 |
0.0017 |
| 565 |
NERVE COMPRESSION |
16 |
0.0017 |
| 566 |
GRAND MAL CONVULSION |
16 |
0.0017 |
| 567 |
PYELONEPHRITIS |
15 |
0.0017 |
| 568 |
NOCTURIA |
21 |
0.0017 |
| 569 |
DEAFNESS |
45 |
0.0017 |
| 570 |
TRANSIENT ISCHAEMIC ATTACK |
58 |
0.0017 |
| 571 |
HYPOACUSIS |
74 |
0.0017 |
| 572 |
VISUAL IMPAIRMENT |
213 |
0.0017 |
| 573 |
OEDEMA |
93 |
0.0017 |
| 574 |
ALANINE AMINOTRANSFERASE INCREASED |
105 |
0.0017 |
| 575 |
HYPERTHERMIA |
13 |
0.0017 |
| 576 |
EAR PAIN |
33 |
0.0017 |
| 577 |
DIABETES MELLITUS INADEQUATE CONTROL |
30 |
0.0017 |
| 578 |
MUSCULOSKELETAL DISCOMFORT |
29 |
0.0017 |
| 579 |
FEMUR FRACTURE |
52 |
0.0017 |
| 580 |
SKIN DISORDER |
56 |
0.0017 |
| 581 |
RECALLED PRODUCT ADMINISTERED |
16 |
0.0017 |
| 582 |
JOINT STIFFNESS |
44 |
0.0017 |
| 583 |
VOMITING |
787 |
0.0017 |
| 584 |
FATIGUE |
1299 |
0.0017 |
| 585 |
NERVOUS SYSTEM DISORDER |
52 |
0.0017 |
| 586 |
FACE OEDEMA |
28 |
0.0017 |
| 587 |
LYMPHOCYTE COUNT DECREASED |
29 |
0.0016 |
| 588 |
FEELING ABNORMAL |
393 |
0.0016 |
| 589 |
NEPHROLITHIASIS |
75 |
0.0016 |
| 590 |
DRUG EFFECT INCOMPLETE |
59 |
0.0016 |
| 591 |
CARDIOMYOPATHY |
24 |
0.0016 |
| 592 |
HYPERCALCAEMIA |
20 |
0.0016 |
| 593 |
SKIN HAEMORRHAGE |
24 |
0.0016 |
| 594 |
DISTURBANCE IN ATTENTION |
87 |
0.0016 |
| 595 |
RESPIRATORY DISORDER |
48 |
0.0016 |
| 596 |
ASPARTATE AMINOTRANSFERASE INCREASED |
85 |
0.0016 |
| 597 |
BLOOD BILIRUBIN INCREASED |
43 |
0.0016 |
| 598 |
PRODUCT COMPLAINT |
40 |
0.0016 |
| 599 |
PROTEINURIA |
30 |
0.0016 |
| 600 |
MUSCULOSKELETAL DISORDER |
30 |
0.0016 |
| 601 |
STEVENS-JOHNSON SYNDROME |
35 |
0.0016 |
| 602 |
INSURANCE ISSUE |
24 |
0.0016 |
| 603 |
SOMNOLENCE |
316 |
0.0016 |
| 604 |
COGNITIVE DISORDER |
73 |
0.0016 |
| 605 |
IMMUNODEFICIENCY |
23 |
0.0015 |
| 606 |
GENERALISED OEDEMA |
19 |
0.0015 |
| 607 |
OSTEOPOROSIS |
63 |
0.0015 |
| 608 |
PERIPHERAL COLDNESS |
21 |
0.0015 |
| 609 |
KIDNEY INFECTION |
30 |
0.0015 |
| 610 |
PRODUCT USE ISSUE |
285 |
0.0015 |
| 611 |
GALLBLADDER DISORDER |
27 |
0.0015 |
| 612 |
ASTHENIA |
566 |
0.0015 |
| 613 |
RED BLOOD CELL COUNT DECREASED |
43 |
0.0015 |
| 614 |
CARDIAC MURMUR |
13 |
0.0015 |
| 615 |
HIP ARTHROPLASTY |
23 |
0.0015 |
| 616 |
OEDEMA PERIPHERAL |
183 |
0.0015 |
| 617 |
INJECTION SITE IRRITATION |
19 |
0.0015 |
| 618 |
LOSS OF CONSCIOUSNESS |
191 |
0.0015 |
| 619 |
HYPERSENSITIVITY |
276 |
0.0015 |
| 620 |
INTRAOCULAR PRESSURE INCREASED |
19 |
0.0015 |
| 621 |
SEASONAL ALLERGY |
21 |
0.0015 |
| 622 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
53 |
0.0015 |
| 623 |
INJECTION SITE PRURITUS |
99 |
0.0015 |
| 624 |
LYMPHADENOPATHY |
52 |
0.0015 |
| 625 |
DRUG ABUSE |
122 |
0.0015 |
| 626 |
COVID-19 |
257 |
0.0015 |
| 627 |
ACNE |
111 |
0.0015 |
| 628 |
APPLICATION SITE PAIN |
32 |
0.0015 |
| 629 |
SPLENOMEGALY |
17 |
0.0014 |
| 630 |
PHARYNGITIS |
18 |
0.0014 |
| 631 |
DRUG LEVEL INCREASED |
24 |
0.0014 |
| 632 |
APATHY |
21 |
0.0014 |
| 633 |
AUTOIMMUNE DISORDER |
14 |
0.0014 |
| 634 |
INTENTIONAL SELF-INJURY |
29 |
0.0014 |
| 635 |
MALNUTRITION |
16 |
0.0014 |
| 636 |
ANXIETY |
407 |
0.0014 |
| 637 |
DISCOMFORT |
87 |
0.0014 |
| 638 |
HYPERLIPIDAEMIA |
17 |
0.0014 |
| 639 |
GYNAECOMASTIA |
44 |
0.0014 |
| 640 |
CARDIAC DISORDER |
133 |
0.0014 |
| 641 |
INSOMNIA |
378 |
0.0014 |
| 642 |
INTERVERTEBRAL DISC PROTRUSION |
31 |
0.0014 |
| 643 |
BLOOD POTASSIUM INCREASED |
23 |
0.0014 |
| 644 |
CIRCULATORY COLLAPSE |
24 |
0.0014 |
| 645 |
CHOLELITHIASIS |
46 |
0.0014 |
| 646 |
BRONCHOSPASM |
20 |
0.0014 |
| 647 |
PARALYSIS |
20 |
0.0014 |
| 648 |
CEREBROVASCULAR ACCIDENT |
236 |
0.0014 |
| 649 |
OROPHARYNGEAL PAIN |
128 |
0.0014 |
| 650 |
CARDIOMEGALY |
17 |
0.0014 |
| 651 |
RHINORRHOEA |
89 |
0.0014 |
| 652 |
DRUG LEVEL DECREASED |
14 |
0.0014 |
| 653 |
DIABETIC KETOACIDOSIS |
33 |
0.0014 |
| 654 |
VASCULITIS |
16 |
0.0014 |
| 655 |
SKIN DISCOLOURATION |
63 |
0.0014 |
| 656 |
BLOOD URINE PRESENT |
26 |
0.0014 |
| 657 |
CONDITION AGGRAVATED |
416 |
0.0014 |
| 658 |
DEVICE RELATED INFECTION |
21 |
0.0014 |
| 659 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
97 |
0.0014 |
| 660 |
MYALGIA |
231 |
0.0014 |
| 661 |
HEMIPARESIS |
23 |
0.0014 |
| 662 |
HEAD DISCOMFORT |
24 |
0.0014 |
| 663 |
ABDOMINAL PAIN UPPER |
277 |
0.0013 |
| 664 |
HERNIA |
26 |
0.0013 |
| 665 |
MIDDLE INSOMNIA |
25 |
0.0013 |
| 666 |
EPISTAXIS |
100 |
0.0013 |
| 667 |
OCULAR DISCOMFORT |
15 |
0.0013 |
| 668 |
STAPHYLOCOCCAL INFECTION |
44 |
0.0013 |
| 669 |
SINUSITIS |
136 |
0.0013 |
| 670 |
OSTEOARTHRITIS |
56 |
0.0013 |
| 671 |
UNRESPONSIVE TO STIMULI |
34 |
0.0013 |
| 672 |
FEELING HOT |
80 |
0.0013 |
| 673 |
HYPERHIDROSIS |
168 |
0.0013 |
| 674 |
GASTRIC HAEMORRHAGE |
15 |
0.0013 |
| 675 |
ABORTION SPONTANEOUS |
52 |
0.0013 |
| 676 |
SWELLING |
121 |
0.0013 |
| 677 |
TENDONITIS |
20 |
0.0013 |
| 678 |
CEREBRAL HAEMORRHAGE |
46 |
0.0013 |
| 679 |
HYPOTHERMIA |
13 |
0.0013 |
| 680 |
MENTAL IMPAIRMENT |
31 |
0.0013 |
| 681 |
BRAIN FOG |
20 |
0.0013 |
| 682 |
SKIN LESION |
35 |
0.0013 |
| 683 |
PRESYNCOPE |
31 |
0.0013 |
| 684 |
BODY TEMPERATURE INCREASED |
26 |
0.0013 |
| 685 |
POLLAKIURIA |
53 |
0.0013 |
| 686 |
FALL |
422 |
0.0013 |
| 687 |
DEPRESSION |
288 |
0.0013 |
| 688 |
PAIN |
777 |
0.0013 |
| 689 |
HYPONATRAEMIA |
71 |
0.0013 |
| 690 |
GASTRITIS |
33 |
0.0013 |
| 691 |
DEMENTIA |
35 |
0.0013 |
| 692 |
HYPOPHAGIA |
32 |
0.0013 |
| 693 |
ACCIDENTAL UNDERDOSE |
18 |
0.0012 |
| 694 |
CONJUNCTIVITIS |
23 |
0.0012 |
| 695 |
PNEUMONIA |
401 |
0.0012 |
| 696 |
HEPATIC STEATOSIS |
23 |
0.0012 |
| 697 |
ISCHAEMIC STROKE |
22 |
0.0012 |
| 698 |
DIPLOPIA |
32 |
0.0012 |
| 699 |
URTICARIA |
206 |
0.0012 |
| 700 |
LIMB DISCOMFORT |
38 |
0.0012 |
| 701 |
ACUTE MYELOID LEUKAEMIA |
19 |
0.0012 |
| 702 |
DEHYDRATION |
162 |
0.0012 |
| 703 |
AMNESIA |
79 |
0.0012 |
| 704 |
BACK PAIN |
282 |
0.0012 |
| 705 |
BLINDNESS UNILATERAL |
17 |
0.0012 |
| 706 |
ASTHMA |
136 |
0.0012 |
| 707 |
JOINT SWELLING |
145 |
0.0012 |
| 708 |
BIPOLAR DISORDER |
13 |
0.0012 |
| 709 |
AGITATION |
87 |
0.0012 |
| 710 |
INFECTION |
171 |
0.0012 |
| 711 |
MUSCLE TIGHTNESS |
19 |
0.0012 |
| 712 |
DECREASED APPETITE |
272 |
0.0012 |
| 713 |
PHOTOPHOBIA |
22 |
0.0012 |
| 714 |
OVERDOSE |
252 |
0.0012 |
| 715 |
ROTATOR CUFF SYNDROME |
15 |
0.0012 |
| 716 |
HEART RATE INCREASED |
115 |
0.0012 |
| 717 |
CORONARY ARTERY DISEASE |
35 |
0.0012 |
| 718 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
25 |
0.0012 |
| 719 |
NO THERAPEUTIC RESPONSE |
14 |
0.0011 |
| 720 |
CATARACT |
68 |
0.0011 |
| 721 |
ABDOMINAL PAIN |
265 |
0.0011 |
| 722 |
PNEUMOTHORAX |
18 |
0.0011 |
| 723 |
EYE HAEMORRHAGE |
15 |
0.0011 |
| 724 |
PALPITATIONS |
131 |
0.0011 |
| 725 |
EYELID OEDEMA |
13 |
0.0011 |
| 726 |
RIB FRACTURE |
23 |
0.0011 |
| 727 |
PANCREATITIS ACUTE |
25 |
0.0011 |
| 728 |
SCAR |
19 |
0.0011 |
| 729 |
GAIT DISTURBANCE |
212 |
0.0011 |
| 730 |
GASTRIC DISORDER |
38 |
0.0011 |
| 731 |
GAIT INABILITY |
37 |
0.0011 |
| 732 |
SPEECH DISORDER |
58 |
0.0011 |
| 733 |
HYPERTENSION |
234 |
0.0011 |
| 734 |
CARDIOVASCULAR DISORDER |
28 |
0.0011 |
| 735 |
IMPAIRED GASTRIC EMPTYING |
15 |
0.0011 |
| 736 |
HIP FRACTURE |
35 |
0.0011 |
| 737 |
GENERALISED TONIC-CLONIC SEIZURE |
18 |
0.0011 |
| 738 |
UPPER RESPIRATORY TRACT INFECTION |
50 |
0.0011 |
| 739 |
CYANOSIS |
17 |
0.0011 |
| 740 |
HAEMATOMA |
28 |
0.0011 |
| 741 |
URINARY INCONTINENCE |
32 |
0.0011 |
| 742 |
FEELING COLD |
30 |
0.0011 |
| 743 |
THROAT TIGHTNESS |
29 |
0.0011 |
| 744 |
HAEMORRHAGE |
112 |
0.0011 |
| 745 |
HAEMORRHAGE INTRACRANIAL |
16 |
0.0011 |
| 746 |
SKIN REACTION |
15 |
0.0011 |
| 747 |
SARS-COV-2 TEST POSITIVE |
14 |
0.0011 |
| 748 |
DIZZINESS |
528 |
0.0011 |
| 749 |
VISION BLURRED |
145 |
0.0011 |
| 750 |
BRONCHITIS |
78 |
0.0011 |
| 751 |
OSTEOMYELITIS |
19 |
0.0010 |
| 752 |
KNEE ARTHROPLASTY |
22 |
0.0010 |
| 753 |
QUALITY OF LIFE DECREASED |
14 |
0.0010 |
| 754 |
RASH GENERALISED |
27 |
0.0010 |
| 755 |
ARTHRITIS |
82 |
0.0010 |
| 756 |
HYPOAESTHESIA |
156 |
0.0010 |
| 757 |
NASAL CONGESTION |
61 |
0.0010 |
| 758 |
INFLUENZA LIKE ILLNESS |
85 |
0.0010 |
| 759 |
MUSCULOSKELETAL PAIN |
54 |
0.0010 |
| 760 |
TREMOR |
171 |
0.0010 |
| 761 |
FIBROMYALGIA |
25 |
0.0010 |
| 762 |
EYE PAIN |
58 |
0.0010 |
| 763 |
DEATH |
874 |
0.0010 |
| 764 |
OXYGEN SATURATION DECREASED |
57 |
0.0010 |
| 765 |
PERITONITIS |
21 |
0.0010 |
| 766 |
SINUS DISORDER |
20 |
0.0010 |
| 767 |
TACHYCARDIA |
89 |
0.0010 |
| 768 |
TINNITUS |
46 |
0.0010 |
| 769 |
GASTROINTESTINAL DISORDER |
89 |
0.0010 |
| 770 |
TRANSAMINASES INCREASED |
22 |
0.0010 |
| 771 |
DIALYSIS |
14 |
0.0010 |
| 772 |
GLAUCOMA |
19 |
0.0010 |
| 773 |
DIVERTICULITIS |
27 |
0.0010 |
| 774 |
HAIR TEXTURE ABNORMAL |
13 |
0.0010 |
| 775 |
FAECES DISCOLOURED |
21 |
0.0010 |
| 776 |
VERTIGO |
59 |
0.0010 |
| 777 |
FEAR |
26 |
0.0010 |
| 778 |
NO ADVERSE EVENT |
174 |
0.0010 |
| 779 |
PROSTATE CANCER |
76 |
0.0009 |
| 780 |
ANGINA PECTORIS |
27 |
0.0009 |
| 781 |
MUSCULAR WEAKNESS |
107 |
0.0009 |
| 782 |
ABSCESS |
15 |
0.0009 |
| 783 |
SNEEZING |
21 |
0.0009 |
| 784 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
37 |
0.0009 |
| 785 |
RHABDOMYOLYSIS |
39 |
0.0009 |
| 786 |
SENSORY DISTURBANCE |
15 |
0.0009 |
| 787 |
IRRITABLE BOWEL SYNDROME |
20 |
0.0009 |
| 788 |
MOBILITY DECREASED |
67 |
0.0009 |
| 789 |
ECONOMIC PROBLEM |
14 |
0.0009 |
| 790 |
COUGH |
259 |
0.0009 |
| 791 |
PNEUMONIA ASPIRATION |
23 |
0.0009 |
| 792 |
CHEST PAIN |
170 |
0.0009 |
| 793 |
PSYCHOTIC DISORDER |
27 |
0.0009 |
| 794 |
RESPIRATORY DISTRESS |
25 |
0.0009 |
| 795 |
NIGHT SWEATS |
29 |
0.0009 |
| 796 |
HEPATITIS |
23 |
0.0009 |
| 797 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
43 |
0.0009 |
| 798 |
INFLAMMATION |
46 |
0.0009 |
| 799 |
MUSCULOSKELETAL STIFFNESS |
78 |
0.0009 |
| 800 |
CONSTIPATION |
194 |
0.0009 |
| 801 |
ILL-DEFINED DISORDER |
54 |
0.0009 |
| 802 |
BLOOD CREATININE INCREASED |
58 |
0.0009 |
| 803 |
WITHDRAWAL SYNDROME |
37 |
0.0009 |
| 804 |
PRURITUS GENERALISED |
19 |
0.0009 |
| 805 |
ABDOMINAL DISTENSION |
91 |
0.0009 |
| 806 |
RESPIRATORY ARREST |
24 |
0.0009 |
| 807 |
CHRONIC KIDNEY DISEASE |
66 |
0.0009 |
| 808 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
25 |
0.0009 |
| 809 |
RASH |
378 |
0.0009 |
| 810 |
DRUG INEFFECTIVE |
1137 |
0.0009 |
| 811 |
SEPSIS |
96 |
0.0009 |
| 812 |
ERECTILE DYSFUNCTION |
22 |
0.0009 |
| 813 |
BLOOD PRESSURE ABNORMAL |
17 |
0.0009 |
| 814 |
TOOTH DISORDER |
19 |
0.0009 |
| 815 |
PARAESTHESIA |
134 |
0.0009 |
| 816 |
INJURY |
59 |
0.0008 |
| 817 |
URINARY TRACT INFECTION |
142 |
0.0008 |
| 818 |
LOCALISED INFECTION |
20 |
0.0008 |
| 819 |
SHOCK |
19 |
0.0008 |
| 820 |
MUSCLE TWITCHING |
19 |
0.0008 |
| 821 |
PANIC ATTACK |
30 |
0.0008 |
| 822 |
IMPAIRED HEALING |
27 |
0.0008 |
| 823 |
DYSPHONIA |
48 |
0.0008 |
| 824 |
PRODUCT SUBSTITUTION ISSUE |
47 |
0.0008 |
| 825 |
ACUTE MYOCARDIAL INFARCTION |
24 |
0.0008 |
| 826 |
GENERAL PHYSICAL HEALTH DETERIORATION |
94 |
0.0008 |
| 827 |
MULTI-ORGAN FAILURE |
14 |
0.0008 |
| 828 |
NIGHTMARE |
28 |
0.0008 |
| 829 |
BACTERIAL INFECTION |
15 |
0.0008 |
| 830 |
RASH PAPULAR |
18 |
0.0008 |
| 831 |
SUICIDAL IDEATION |
73 |
0.0008 |
| 832 |
NAUSEA |
630 |
0.0008 |
| 833 |
PANCREATITIS |
42 |
0.0008 |
| 834 |
CELLULITIS |
40 |
0.0008 |
| 835 |
FEEDING DISORDER |
16 |
0.0008 |
| 836 |
COAGULOPATHY |
13 |
0.0008 |
| 837 |
CONFUSIONAL STATE |
126 |
0.0008 |
| 838 |
CEREBRAL INFARCTION |
19 |
0.0008 |
| 839 |
COMA |
37 |
0.0008 |
| 840 |
DRUG INTERACTION |
123 |
0.0008 |
| 841 |
ABDOMINAL DISCOMFORT |
130 |
0.0008 |
| 842 |
ALOPECIA |
152 |
0.0008 |
| 843 |
MUSCLE SPASMS |
142 |
0.0008 |
| 844 |
HAEMOGLOBIN DECREASED |
79 |
0.0008 |
| 845 |
RENAL FAILURE |
101 |
0.0008 |
| 846 |
ARRHYTHMIA |
36 |
0.0008 |
| 847 |
HAEMATURIA |
26 |
0.0008 |
| 848 |
BLOOD PRESSURE INCREASED |
116 |
0.0008 |
| 849 |
HOT FLUSH |
57 |
0.0008 |
| 850 |
BLISTER |
42 |
0.0007 |
| 851 |
SKIN CANCER |
16 |
0.0007 |
| 852 |
NEURALGIA |
18 |
0.0007 |
| 853 |
BLOOD PRESSURE DECREASED |
49 |
0.0007 |
| 854 |
LUNG DISORDER |
36 |
0.0007 |
| 855 |
THROMBOSIS |
59 |
0.0007 |
| 856 |
ENCEPHALOPATHY |
18 |
0.0007 |
| 857 |
PULMONARY FIBROSIS |
14 |
0.0007 |
| 858 |
LACRIMATION INCREASED |
22 |
0.0007 |
| 859 |
URINARY RETENTION |
24 |
0.0007 |
| 860 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
26 |
0.0007 |
| 861 |
END STAGE RENAL DISEASE |
13 |
0.0007 |
| 862 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
128 |
0.0007 |
| 863 |
DISABILITY |
14 |
0.0007 |
| 864 |
WHITE BLOOD CELL COUNT INCREASED |
27 |
0.0007 |
| 865 |
RETCHING |
15 |
0.0007 |
| 866 |
DRY SKIN |
93 |
0.0007 |
| 867 |
ABASIA |
17 |
0.0007 |
| 868 |
CARDIAC FAILURE |
55 |
0.0007 |
| 869 |
DYSSTASIA |
20 |
0.0007 |
| 870 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
20 |
0.0007 |
| 871 |
RENAL IMPAIRMENT |
57 |
0.0007 |
| 872 |
TOOTH LOSS |
14 |
0.0007 |
| 873 |
HEPATIC ENZYME INCREASED |
46 |
0.0007 |
| 874 |
HAEMATEMESIS |
17 |
0.0007 |
| 875 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
30 |
0.0007 |
| 876 |
CHOKING |
13 |
0.0007 |
| 877 |
INTESTINAL OBSTRUCTION |
25 |
0.0007 |
| 878 |
ANAPHYLACTIC SHOCK |
17 |
0.0007 |
| 879 |
DISORIENTATION |
26 |
0.0007 |
| 880 |
ANHEDONIA |
17 |
0.0006 |
| 881 |
DYSARTHRIA |
24 |
0.0006 |
| 882 |
MYOCARDIAL INFARCTION |
111 |
0.0006 |
| 883 |
FLATULENCE |
36 |
0.0006 |
| 884 |
UNEVALUABLE EVENT |
48 |
0.0006 |
| 885 |
ANAEMIA |
121 |
0.0006 |
| 886 |
BREAST CANCER |
59 |
0.0006 |
| 887 |
DRUG INTOLERANCE |
61 |
0.0006 |
| 888 |
LIP SWELLING |
21 |
0.0006 |
| 889 |
CYSTITIS |
20 |
0.0006 |
| 890 |
METABOLIC ACIDOSIS |
20 |
0.0006 |
| 891 |
DYSURIA |
23 |
0.0006 |
| 892 |
HYPOXIA |
22 |
0.0006 |
| 893 |
MATERNAL EXPOSURE DURING PREGNANCY |
55 |
0.0006 |
| 894 |
DIARRHOEA |
398 |
0.0006 |
| 895 |
LIVER DISORDER |
27 |
0.0006 |
| 896 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
33 |
0.0006 |
| 897 |
MENSTRUATION IRREGULAR |
16 |
0.0006 |
| 898 |
CARDIAC ARREST |
49 |
0.0006 |
| 899 |
ECZEMA |
31 |
0.0006 |
| 900 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
21 |
0.0006 |
| 901 |
HAEMATOCHEZIA |
32 |
0.0006 |
| 902 |
C-REACTIVE PROTEIN INCREASED |
21 |
0.0006 |
| 903 |
RESPIRATORY FAILURE |
42 |
0.0006 |
| 904 |
HEART RATE IRREGULAR |
13 |
0.0006 |
| 905 |
CARDIO-RESPIRATORY ARREST |
24 |
0.0006 |
| 906 |
RESTLESSNESS |
21 |
0.0006 |
| 907 |
RASH MACULAR |
20 |
0.0006 |
| 908 |
RASH PRURITIC |
31 |
0.0006 |
| 909 |
GASTROOESOPHAGEAL REFLUX DISEASE |
46 |
0.0006 |
| 910 |
DISEASE PROGRESSION |
67 |
0.0006 |
| 911 |
DYSKINESIA |
23 |
0.0006 |
| 912 |
ANGIOEDEMA |
25 |
0.0006 |
| 913 |
NEUTROPHIL COUNT DECREASED |
23 |
0.0006 |
| 914 |
AGEUSIA |
14 |
0.0006 |
| 915 |
MOVEMENT DISORDER |
18 |
0.0006 |
| 916 |
COLITIS ULCERATIVE |
25 |
0.0006 |
| 917 |
THERAPY NON-RESPONDER |
25 |
0.0006 |
| 918 |
DYSPNOEA |
309 |
0.0005 |
| 919 |
ANAPHYLACTIC REACTION |
30 |
0.0005 |
| 920 |
WHITE BLOOD CELL COUNT DECREASED |
58 |
0.0005 |
| 921 |
CONTRAINDICATED PRODUCT ADMINISTERED |
16 |
0.0005 |
| 922 |
COLITIS |
20 |
0.0005 |
| 923 |
ADVERSE DRUG REACTION |
47 |
0.0005 |
| 924 |
CHILLS |
60 |
0.0005 |
| 925 |
THERAPEUTIC RESPONSE DECREASED |
31 |
0.0005 |
| 926 |
BALANCE DISORDER |
44 |
0.0005 |
| 927 |
WHEEZING |
30 |
0.0005 |
| 928 |
ADVERSE EVENT |
46 |
0.0005 |
| 929 |
CHEST DISCOMFORT |
50 |
0.0005 |
| 930 |
LUNG NEOPLASM MALIGNANT |
20 |
0.0005 |
| 931 |
LIVER FUNCTION TEST ABNORMAL |
14 |
0.0005 |
| 932 |
HYPOKALAEMIA |
22 |
0.0005 |
| 933 |
PULMONARY EMBOLISM |
45 |
0.0005 |
| 934 |
ERYTHEMA |
97 |
0.0005 |
| 935 |
DYSGEUSIA |
35 |
0.0005 |
| 936 |
DRUG WITHDRAWAL SYNDROME |
41 |
0.0005 |
| 937 |
HALLUCINATION |
35 |
0.0005 |
| 938 |
SUICIDE ATTEMPT |
28 |
0.0005 |
| 939 |
PRODUCTIVE COUGH |
22 |
0.0005 |
| 940 |
RASH ERYTHEMATOUS |
22 |
0.0005 |
| 941 |
PLEURAL EFFUSION |
28 |
0.0005 |
| 942 |
SEPTIC SHOCK |
20 |
0.0005 |
| 943 |
HEART RATE DECREASED |
16 |
0.0005 |
| 944 |
HYPOTENSION |
91 |
0.0005 |
| 945 |
PULMONARY OEDEMA |
20 |
0.0004 |
| 946 |
OCULAR HYPERAEMIA |
21 |
0.0004 |
| 947 |
RECTAL HAEMORRHAGE |
19 |
0.0004 |
| 948 |
PLATELET COUNT DECREASED |
47 |
0.0004 |
| 949 |
PRURITUS |
168 |
0.0004 |
| 950 |
DEVICE DISLOCATION |
19 |
0.0004 |
| 951 |
ATRIAL FIBRILLATION |
42 |
0.0004 |
| 952 |
CARDIAC FAILURE CONGESTIVE |
34 |
0.0004 |
| 953 |
DYSPHAGIA |
40 |
0.0004 |
| 954 |
DRY MOUTH |
34 |
0.0004 |
| 955 |
BRADYCARDIA |
21 |
0.0004 |
| 956 |
EMOTIONAL DISTRESS |
47 |
0.0004 |
| 957 |
NEUROPATHY PERIPHERAL |
36 |
0.0004 |
| 958 |
MULTIPLE SCLEROSIS |
18 |
0.0004 |
| 959 |
THROMBOCYTOPENIA |
42 |
0.0004 |
| 960 |
HEPATIC FUNCTION ABNORMAL |
14 |
0.0004 |
| 961 |
DRUG EFFECT DECREASED |
20 |
0.0004 |
| 962 |
ACUTE KIDNEY INJURY |
56 |
0.0004 |
| 963 |
HERPES ZOSTER |
21 |
0.0004 |
| 964 |
DERMATITIS ATOPIC |
19 |
0.0004 |
| 965 |
THROAT IRRITATION |
16 |
0.0004 |
| 966 |
FLUSHING |
36 |
0.0004 |
| 967 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
25 |
0.0004 |
| 968 |
DYSPEPSIA |
34 |
0.0003 |
| 969 |
LEUKOPENIA |
17 |
0.0003 |
| 970 |
RENAL FAILURE ACUTE |
14 |
0.0003 |
| 971 |
SKIN EXFOLIATION |
26 |
0.0003 |
| 972 |
STOMATITIS |
18 |
0.0003 |
| 973 |
EYE IRRITATION |
17 |
0.0003 |
| 974 |
GASTROINTESTINAL HAEMORRHAGE |
24 |
0.0003 |
| 975 |
BLADDER CANCER |
15 |
0.0003 |
| 976 |
INTENTIONAL OVERDOSE |
16 |
0.0002 |
| 977 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
13 |
0.0002 |
| 978 |
FOETAL EXPOSURE DURING PREGNANCY |
20 |
0.0002 |
| 979 |
EXPOSURE DURING PREGNANCY |
15 |
0.0002 |
| 980 |
NEUTROPENIA |
32 |
0.0002 |
| 981 |
DEEP VEIN THROMBOSIS |
15 |
0.0002 |
| 982 |
RHEUMATOID ARTHRITIS |
21 |
0.0002 |
| 983 |
TREATMENT FAILURE |
14 |
0.0002 |
| 984 |
PSORIASIS |
18 |
0.0001 |
| 985 |
DRUG DEPENDENCE |
21 |
0.0001 |